Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia
Küçük Resim Yok
Tarih
1999
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Excerpta Medica Inc
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
This randomized prospective clinical study evaluated the lipid-lowering effects and safety of a new combination regimen in patients with mixed hyperlipidemia. The data show that alternate-day simvastatin and fenofibrate therapy was as effective as the standard daily combination of the same drugs at the same doses, and it was safer, less expensive, and more tolerable.
Açıklama
Anahtar Kelimeler
Kaynak
American Journal of Cardiology
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
83
Sayı
7
